The Pancreas - An Integrated Textbook of Basic Science, Medicine, and Surgery

The Pancreas - An Integrated Textbook of Basic Science, Medicine, and Surgery

von: Hans G. Beger, Andrew L. Warshaw, Ralph H. Hruban, Markus W. Buchler, Markus M. Lerch, John P. Neoptolemos, Tooru Shimosegawa, David C. Whitcomb

Wiley-Blackwell, 2018

ISBN: 9781119188407 , 1216 Seiten

3. Auflage

Format: PDF

Kopierschutz: DRM

Mac OSX,Windows PC Apple iPad, Android Tablet PC's

Preis: 404,99 EUR

eBook anfordern eBook anfordern

Mehr zum Inhalt

The Pancreas - An Integrated Textbook of Basic Science, Medicine, and Surgery


 

Title Page

3

Copyright Page

4

Contents

5

Contributors

15

Preface

31

Abbreviations

32

About the Companion Website

44

Section 1 Anatomy of the Pancreas

45

Chapter 1 Development of the Pancreas and Related Structures

47

Anatomy of the Pancreas

47

Organogenesis in the Region of the Pancreas

47

Early Pancreatic Development

48

Differentiation of Pancreas Cell Types

49

Transcriptional Mechanisms Underlying Pancreatic Cell Fate Decision

50

Development and Disease

50

Acknowledgment

51

References

51

Chapter 2 Anatomy, Histology, and Fine Structure of the Pancreas

54

Introduction

54

Gross Anatomy

54

Histology and Ultrastructure

57

Endocrine Pancreas

64

Acknowledgments

66

References

67

Chapter 3 Congenital and Inherited Anomalies of the Pancreas

68

Introduction

68

Primary Malformations

68

Isolated Congenital Disorders of Pancreatic Endocrine Function

75

Other Hereditary Disorders with Variable Pancreatic Involvement and Metabolic Diseases Affecting the Pancreas

76

Inherited Metabolic Disorders Affecting the Pancreas

77

References

79

Section 2 Physiology and Pathophysiology of Pancreatic Functions

85

Chapter 4 Physiology of Acinar Cell Secretion

87

Introduction

87

Composition of Pancreatic Acinar Juice

87

Acinar Fluid and Enzyme Secretion

88

Ca2+ Signaling

89

Organelles Important for Ca2+ Homeostasis

90

Mechanisms of Ca2+ Signal Generation

92

Ca2+ Entry and Exit

94

Ca2+-Mediated Control of Enzyme Secretion

95

Ca2+-Mediated Control of Fluid Secretion

96

Dangers of Ca2+ Signaling

96

References

97

Chapter 5 Physiology of Duct Cell Secretion

100

Introduction

100

Sequential Secretion by Acinar and Duct Cells

100

Regulation of Ductal Secretion

102

The Ca2+ and cAMP Pathways Synergize to Activate Ductal Secretion

104

Ductal Secretion-Associated Pancreatic Diseases

104

Acknowledgment

104

References

104

Chapter 6 Pathophysiology of Experimental Pancreatitis

107

Introduction

107

Models of Acute Pancreatitis

107

Phases of Acute Pancreatitis

108

Early Intra-Acinar Events in Acute Pancreatitis

108

Conclusion

116

References

116

Chapter 7 Physiology and Pathophysiology of Function of Sphincter of Oddi

119

Introduction

119

Anatomy and Morphology

119

Innervation

120

Physiology

120

Motility of the Sphincter of Oddi

121

Sphincter of Oddi Motility Studies in Animals

121

Sphincter of Oddi Motility in Humans

122

Pathophysiology of the Sphincter of Oddi Dysfunction (SOD)

123

Conclusion

125

References

125

Chapter 8 Neurohormonal and Hormonal Control of Pancreatic Secretion

128

Introduction

128

Stimulation of Pancreatic Secretion

128

Inhibition of Pancreatic Secretion

132

Feedback Regulation of Pancreatic Secretion

133

Conclusion

134

References

134

Chapter 9 Regulation of Pancreatic Protein Synthesis and Growth

139

Introduction

139

Regulation of Protein Synthesis

139

Regulation of Pancreatic Growth

142

References

145

Chapter 10 Fibrogenesis in the Pancreas: The Role of Stellate Cells

150

Introduction

150

Pancreatic Stellate Sells (PSC)

150

Acute Pancreatitis

153

Chronic Pancreatitis

153

Pancreatic Cancer

155

Conclusion

156

References

156

Chapter 11 Fibrogenesis of the Pancreas: The Role of Macrophages

161

Introduction

161

Macrophages

161

Origin and Characteristics of Pancreatic Macrophages

162

Role of Macrophages in Chronic Pancreatitis-Associated Fibrosis

163

Role of Macrophages in Pancreatic Cancer-Associated Fibrosis

164

Conclusion

164

References

165

Chapter 12 Insulo–Acinar Relationship

167

Introduction

167

Structural Relationships Between Pancreatic Islets and Exocrine Pancreas

167

Insulo-Acinar Portal System

168

Regulation of Pancreatic Exocrine Secretion by Islet Hormones

168

Pancreatic Exocrine Function and Diabetes Mellitus

171

References

172

Section 3 Acute Pancreatitis

177

Chapter 13 Epidemiology and Etiology of Alcohol?Induced Pancreatitis

179

Introduction

179

Epidemiology

179

Pathogenesis

179

Summary

186

Acknowledgment

186

References

186

Chapter 14 Epidemiology and Etiology of Acute Biliary Pancreatitis

190

Introduction

190

Etiology of Gallstone Pancreatitis

190

Epidemiology of Biliary Acute Pancreatitis

194

References

197

Chapter 15 Genetic Factors in Acute Pancreatitis

202

Introduction

202

Genetic Susceptibility Factors

202

Multiple Genetic Defects and Susceptibility

205

Progression to Chronic Pancreatitis

206

Future Directions

206

References

207

Chapter 16 The Role of the Intestine and Mesenteric Lymph in the Development of Systemic Inflammation and MODS in Severe Acute Pancreatitis

210

Introduction

210

Role of the Intestine and Mesenteric Lymph in Multiple Organ Dysfunction Syndrome

210

Role of the Intestine in Severe Acute Pancreatitis

211

Altered Gut–Lymph Composition in Acute Pancreatitis

212

Gut–Lymph Toxicity in Acute Pancreatitis

213

Translating the Gut–Lymph Concept to Clinical Treatments for Acute Pancreatitis

213

Conclusion

214

References

214

Chapter 17 The Role of Neurogenic Inflammation in Pancreatitis

217

References

219

Chapter 18 Molecular, Biochemical, and Metabolic Abnormalities in Acute Pancreatitis

222

Introduction

222

Molecular and Biochemical Abnormalities

222

Metabolic and Systemic Abnormalities

225

Electrocardiographic Abnormalities in Acute Pancreatitis

229

References

231

Chapter 19 Histopathology of Acute Pancreatitis

237

Introduction

237

Definition

237

Histopathologic Patterns of Tissue Necrosis

237

Acute Pancreatitis with Type 1 Necrosis Pattern

237

Acute Pancreatitis with Type 2 Necrosis Pattern

240

Acute Pancreatitis with Type 3 Necrosis Pattern

240

Histopathology Related to Etiologic Factors and Pathophysiologic Mechanisms

240

Unsolved Questions

241

References

241

Chapter 20 Clinical Classification Systems of Acute Pancreatitis

243

Introduction

243

Reasons for Classifying the Severity of Acute Pancreatitis

243

New Classification Systems

243

Validation and Comparison of Classification Systems

244

Future of Classification Systems

244

Conclusions

246

References

246

Chapter 21 Clinical Assessment and Biochemical Markers to Objectify Severity and Prognosis

248

Introduction

248

Historical Perspectives: Approaches to Severity Assessment

248

Dynamics of Organ Failure

249

Multiparameter Scoring Systems

249

Laboratory Variables

251

Overview

253

References

253

Chapter 22 Acute Pancreatitis Associated With Congenital Anomalies

257

Introduction

257

Pancreas Divisum

257

Anomalous Pancreaticobiliary Ductal Union

258

Choledochal Cyst/Choledochocele

258

Annular Pancreas

259

Ectopic Pancreatic Tissue

259

Enteric Duplication Cysts

259

Conclusions

260

References

260

Chapter 23 Acute Pancreatitis in Children

263

Introduction

263

Incidence

263

Etiology

263

Pathophysiology

264

Investigations

264

Diagnosis

266

Imaging

268

Management

269

Outcomes

270

Acute Recurrent Pancreatitis

270

References

271

Chapter 24 Acute Pancreatitis Associated With Metabolic Disorders, Infectious Diseases, or Drugs

274

Introduction

274

Metabolic Diseases

274

Infectious Diseases

275

Drug-Related Diseases

276

References

279

Chapter 25 Radiologic Diagnosis and Staging of Severe Acute Pancreatitis

282

Introduction

282

Classification of Acute Pancreatitis

282

Radiographic Diagnosis of Severe Acute Pancreatitis

285

Diagnosis of Local Complications of Acute Pancreatitis

286

Radiologic Staging of Severe Acute Pancreatitis

288

Limitations and Pitfalls of Radiological Diagnosis of Acute Pancreatitis

289

References

292

Clinical Course and Medical Treatment of Acute Pancreatitis

295

Chapter 26 Conservative Therapy of Acute Pancreatitis: Volume Substitution and Enteral and Parenteral Nutrition

295

Introduction

295

Fluid Resuscitation

295

Enteral and Parenteral Nutrition

298

Conclusions

299

References

299

Chapter 27 ICU Treatment of Severe Acute Pancreatitis

302

Introduction

302

Pre?ICU Management

302

Special Considerations

304

Indications for ICU Admission

304

ICU Treatment of Severe Acute Pancreatitis

305

Early ICU Management (0–48 Hours from Onset of Pain)

305

Management of Metabolic Derangements

306

Late ICU Management (>48?Hours After the Onset of Pain)

306

Management of Infectious Risks

307

Transition Planning

307

References

307

Chapter 28 Use of Antibiotics in Severe Acute Pancreatitis: Indications and Limitations

309

Introduction

309

Infectious Complications

309

Spectrum of Bacteria

310

Rationales for Antibiotics in Acute Pancreatitis

310

Clinical Studies with Antibiotics

311

Indications for Antibiotic Treatment

311

Limitations of Antibiotic Treatment

313

References

313

Interventional and Surgical Management of Acute Pancreatitis

315

Chapter 29 Indications for Interventional and Surgical Treatment of Necrotizing Pancreatitis

315

Introduction

315

Interventions for Pancreatic Necrosis: Historical Perspective

315

Indications and Timing of Intervention

316

Pancreatic Necrosis with Infection

316

Symptomatic Pancreatic Necrosis/Walled-Off Necrosis

316

Surgical and Interventional Procedures

317

Surgical Debridement

317

Percutaneous Catheter Drainage

318

Direct Endoscopic Necrosectomy

319

References

319

Chapter 30 Management of Infected Pancreatic Necroses: An Endoscopic Approach

321

Pancreatic Necrosis

321

Mechanical Intervention

321

Transmural Drainage

322

Results of Endoscopic Therapy of Pancreatic Necrosis

324

Adverse Events of Endoscopic Therapy of Pancreatic Necrosis

324

References

325

Chapter 31 Minimally Invasive Debridement and Lavage of Necrotizing Pancreatitis

327

Introduction

327

Technique

327

Techniques for Complex Collections

329

Early Complications

330

Postoperative Course

330

Outcome

331

References

331

Chapter 32 Open Surgical Debridement in Necrotizing Pancreatitis

333

Introduction

333

General Technique of Open Surgical Debridement

333

Continuous Closed Lavage

334

Debridement and Open Packing/Staged Laparotomy

334

Debridement and Closed Packing

336

Open Cystogastrostomy for Walled?Off Pancreatic Necrosis

337

Conclusion

337

References

338

Chapter 33 Endoscopic Treatment of Biliary Acute Pancreatitis

340

Pathogenesis of Acute Biliary Pancreatitis

340

Diagnosis

340

Indication of Endoscopic Treatment

340

Techniques

341

Outcomes and Timing of Endoscopic Interventions

341

Cholecystectomy After Endoscopic Treatment

343

References

343

Chapter 34 Strategies for the Treatment of Pancreatic Pseudocysts and Walled-Off Necrosis After Acute Pancreatitis: Interventional Endoscopic Approaches

345

Introduction

345

Indications for Endoscopic Treatment

345

Endoscopic Drainage vs. Necrosectomy: Choosing the Right Patient

345

Preventing Recurrence by Treating Disconnected Duct Syndrome

346

References

346

Chapter 35 Strategies for the Treatment of Pancreatic Pseudocysts and Walled-Off Necrosis After Acute Pancreatitis: Surgical Treatment

349

Introduction

349

Definition of Pancreatic Pseudocyst and Walled?Off Necrosis

349

Indications for Surgical Intervention

350

Timing of Interventions and Optimal Interventional Strategy for Walled?Off Necrosis

350

Surgical Intervention for PPC

351

References

352

Chapter 36 Management of Fluid Collection in Acute Pancreatitis

355

Introduction

355

Definitions

355

Imaging of Acute Fluid Collections

356

Conservative Treatment of Pancreatitis and Pancreatic Fluid Collections

356

Conclusion

358

References

358

Chapter 37 Management of Pancreatic Fistula in Acute Pancreatitis

360

Introduction

360

Pathogenesis and Classification

360

Diagnosis

362

Management of External Fistulas

362

Management of Internal Fistulas

364

Conclusions

364

References

365

Long-Term Outcome After Treatment of Acute Pancreatitis

367

Chapter 38 Long-Term Outcome After Acute Pancreatitis

367

Introduction

367

Risk Factors

368

Endocrine Pancreatic Dysfunction

368

Exocrine Dysfunction

368

Recurrent Pancreatitis and Chronic Pancreatitis

369

Quality of Life and Pain

370

Incisional Hernia

371

Pancreatic Cancer and  Pancreas?Related Death

371

Imaging Findings

371

Postpancreatitis Care and Follow?Up Visits

371

Conclusions

372

References

372

Section 4 Chronic Pancreatitis

375

Chapter 39 Molecular Understanding of Chronic Pancreatitis

377

Introduction

377

Risk Factors in Chronic Pancreatitis

377

Sentinel Acute Pancreatic Event Model

378

Epigenetics as a Modifying Factor in Chronic Pancreatitis

380

Environmental Exposures as Modifying Factors in Chronic Pancreatitis

380

Genetic Influences in Chronic Pancreatitis

381

Inflammatory Response in Chronic Pancreatitis

381

Fibrogenesis in Chronic Pancreatitis

382

Conclusions

382

References

383

Chapter 40 Epidemiology and Pathophysiology of Alcoholic Chronic Pancreatitis

386

Introduction

386

Epidemiology of Alcoholic Chronic Pancreatitis

386

Pathophysiology

387

Co-Predisposing Factors for the Development of Alcoholic Chronic Pancreatitis

389

References

390

Chapter 41 Pain Mechanisms in Chronic Pancreatitis

393

Introduction

393

Extrapancreatic Pain

393

Pancreatic Pain

394

Neural Remodeling

394

Conclusions

396

References

397

Chapter 42 Natural History of Recurrent Acute and Chronic Pancreatitis

399

Introduction

399

Natural History After First Attack of Acute Pancreatitis

399

Natural History of Chronic Pancreatitis

403

Conclusion

406

Chapter 43 Chronic Pancreatitis with Inflammatory Mass of the Pancreatic Head

409

Introduction

409

Incidence

409

Symptoms, Pathophysiology, and Clinical Problems

409

Clinical Workup and Differential Diagnosis

410

Treatment

411

Conclusions

412

References

412

Chapter 44 Early Chronic Pancreatitis

415

Introduction

415

Diagnosis of Early Chronic Pancreatitis

415

References

416

Chapter 45 Hereditary Chronic Pancreatitis: Molecular Pattern, Clinical Consequences, and Management Principles

418

Clinical and Genetic Definitions

418

Epidemiology

418

Clinical Presentation

419

Management

420

Molecular Genetics

421

Genetic Testing and Counseling

423

References

424

Chapter 46 Epidemiology and Pathophysiology of Tropical Chronic Pancreatitis

428

Introduction

428

Pathophysiology

429

Natural History of the Disease

431

Conclusion

431

References

431

Chapter 47 Cystic Fibrosis (CFTR)-Associated Pancreatic Disease

435

Introduction

435

Pathophysiology—Genotype and Phenotype Correlations

435

Clinical Manifestations

436

Diagnosis

437

Therapy

437

References

438

Chapter 48 Clinical and Laboratory Diagnosis of Chronic Pancreatitis

441

Introduction

441

Clinical Presentation

441

Etiology

442

Pain

442

Malabsorption and Weight Loss

443

Endocrine Insufficiency

443

Jaundice

444

Laboratory Diagnosis

444

Conclusion

446

References

446

Chapter 49 Evidence of Contrast-Enhanced CT and MRI/MRCP

450

Introduction

450

Diagnosis of Chronic Pancreatitis

451

Differential Diagnosis of Mass-Forming Chronic Pancreatitis and Pancreatic Cancer

455

CT and MRI for Autoimmune Pancreatitis

455

CT and MRI for Groove Pancreatitis

456

Complications of Chronic Pancreatitis

457

References

459

Chapter 50 Chronic Pancreatitis: Risk Factors in Cancer

461

Introduction

461

Descriptive Findings

461

Measuring the Strength of the Pancreatitis–Pancreatic Cancer Association

461

Discussion

462

References

464

Conservative Treatment of Chronic Pancreatitis

465

Chapter 51 Pain Management in Chronic Pancreatitis

465

Introduction

465

Neuropathologic Theory

465

The Plumbing Theory

465

Pain Measurement

466

Treatment Options for Patients with Chronic Pancreatitis

467

Timing

468

Conclusions

468

References

468

Chapter 52 Medical Treatment of Chronic Pancreatitis: Pancreatic Digestive Enzymes: Lipases, Proteases:

470

Introduction

470

Management of Exocrine Pancreatic Insufficiency

470

Emerging Therapies

472

References

472

Chapter 53 Nutritional Support of Chronic Pancreatitis

473

Introduction

473

Undernutrition

473

Nutrient Deficiency

473

Micronutrient Supplementation

474

Osteoporosis and Bone Health

474

Dietary Intervention

474

Enteral and Parenteral Nutrition

475

Combined Pancreatic Exocrine and Endocrine Deficiency

475

Structured Nutritional Assessment

475

References

476

Chapter 54 Medical Therapy for Chronic Pancreatitis: Antioxidants

479

Introduction

479

Pain and Oxidative Stress

479

Clinical Studies of Antioxidants for Pain

480

Conclusions

481

References

481

Strategies for Endoscopic and Surgical Treatment of Chronic Pancreatitis

483

Chapter 55 Evidence of Endoscopic and Interventional Treatment of Chronic Pancreatitis and Pseudocysts

483

Indications for Interventional Endoscopic or Surgical Therapy

483

Treatment of Pancreatic Cysts

484

Therapy of Pancreatic Duct Stenoses and Ductal Stones

486

Endoscopic Treatment of Bile Duct Obstruction

488

References

489

Chapter 56 Indications and Goals of Surgical Treatment

493

Introduction

493

Surgical Drainage of the Pancreatic Duct

493

Surgical Resection of the Pancreas

494

Surgical Management of Biliary Obstruction

495

References

496

Chapter 57 Pancreatic Duct Drainage Procedure

497

Introduction

497

Indication for Surgery

497

Drainage Procedures

498

Conclusion

499

References

499

Chapter 58 Duodenum-Preserving Pancreatic Head Resection

502

Introduction

502

Are Duct Stenting and Endoscopic Interventions an Alternative to Surgery?

502

Who Benefits from Surgical Treatment?

503

Kausch–Whipple Resection or Hemipancreatectomy—Still Standard Treatment for Chronic Pancreatitis?

503

Indications and Rationale for Duodenum?Preserving Pancreatic Head Resection

503

Surgical Technique of DPPHR for Chronic Pancreatitis

504

Early Postoperative Course

504

Long-Term Outcome After DPPHR

506

The Frey Procedure—an Alternative Surgical Approach for all Patients with Chronic Pancreatitis?

507

Summary

508

References

508

Chapter 59 Major Pancreatic Resection

511

Overview

511

Major Pancreatic Resection

511

Pancreatoduodenectomy

513

Distal Pancreatectomy

519

Total Pancreatectomy

520

References

521

Chapter 60 Laparoscopic Surgery

523

Introduction

523

Resection Procedures

523

Drainage Procedures

527

Combination Procedures (Resection and Drainage)

528

Patient Selection

529

Conclusion

530

References

530

Management of Diabetes and Long-Term Outcome of Chronic Pancreatitis

532

Chapter 61 Chronic Pancreatitis: Long-Term Outcome After Medical and Surgical Treatment

532

Introduction

532

Outcomes of Interventional and Surgical Therapy for Pancreatic Pseudocysts

532

Outcome of Pain Management in Chronic Pancreatitis

533

Outcome of Therapeutic Options for Biliary and Pancreatic Ductal Stenoses

535

Conclusion

536

References

536

Chapter 62 Management of Pancreatic Diabetes Secondary to Chronic Pancreatitis

539

Introduction

539

Definition and Prevalence of Pancreatic Diabetes

539

Incidence of Diabetes in Chronic Pancreatitis

539

Risk Factors for Pancreatic Diabetes in Chronic Pancreatitis

540

Pathogenesis of Pancreatic Diabetes

540

Diagnosis of Type 3c Diabetes

541

Clinical Characteristics of Pancreatic Diabetes

541

Complications of Pancreatic Diabetes

542

Therapy of Pancreatic Diabetes

542

Prognosis of Pancreatic Diabetes

544

References

544

Section 5 Autoimmune Pancreatitis

547

Chapter 63 Epidemiology of Autoimmune Pancreatitis

549

Introduction

549

Nationwide Survey of Autoimmune Pancreatitis in Japan

549

First International Survey of Autoimmune Pancreatitis

549

Second International Survey of Autoimmune Pancreatitis

550

Third International Survey of Autoimmune Pancreatitis

550

Conclusions

551

References

552

Chapter 64 Pathogenesis of Autoimmune Pancreatitis

554

Introduction

554

Type 1 Autoimmune Pancreatitis

554

Type 2 Autoimmune Pancreatitis

557

References

558

Chapter 65 Histology of Autoimmune Pancreatitis

560

Introduction

560

Type 1 Autoimmune Pancreatitis

560

Pancreatic Cancer and Autoimmune Pancreatitis

561

Type 2 Autoimmune Pancreatitis

562

Unclassified Autoimmune Pancreatitis

562

Conclusions

562

References

563

Chapter 66 Clinical Manifestation of Type 1 Autoimmune Pancreatitis

564

Type 1 and Type 2 Autoimmune Pancreatitis

564

International Consensus Diagnostic Criteria (ICDC) for Autoimmune Pancreatitis

565

Clinical Features of Type 1 Autoimmune Pancreatitis

565

IgG4-Related Disease (IgG4-RD)

574

References

574

Chapter 67 Clinical Manifestations of Type 2 Autoimmune Pancreatitis

578

Introduction

578

Search Criteria

578

Historical Perspective

578

Terminology

578

Epidemiology

579

Demographics

579

Disease Associations

579

Clinical Symptoms and Signs

579

Diagnosis

580

Differential Diagnosis

580

Treatment

580

Disease Relapse

580

Clinical Course and Outcome

581

Summary

581

References

581

Chapter 68 Laboratory Diagnosis of Autoimmune Pancreatitis

583

Introduction

583

Serum Markers

583

Markers of Autoimmunity

584

Other Markers

585

Conclusion

585

References

586

Chapter 69 What is the Evidence Measuring Immune Markers

588

Introduction

588

Evidence of the Utility of Markers in Autoimmune Pancreatitis Diagnosis

588

Evidence of the Utility of Markers in Differentiating Autoimmune Pancreatitis from Mimicking Conditions

589

Evidence of the Utility of Markers in Predicting Relapse

590

Acknowledgments

591

References

591

Chapter 70 Imaging Diagnosis of Autoimmune Pancreatitis

594

Introduction

594

Pancreatic Parenchyma Imaging

594

Pancreatic Duct Imaging

596

Acknowledgment

597

References

597

Chapter 71 Medical Management of Autoimmune Pancreatitis

599

Introduction

599

Management of Autoimmune Pancreatitis: An Overview

599

Definitions

599

Management of Initial Presentation

600

Management of Relapse

600

Follow-Up and Management of Disease-Related Sequelae

601

Risk of Pancreatic Malignancy

601

Management of Medication Side-Effects

601

Management of Idiopathic Duct-Centric Pancreatitis

602

Conclusion

603

References

603

Long-Term Outcome of Management of Autoimmune Pancreatitis

604

Chapter 72 Long-Term Outcome After Treatment of Autoimmune Pancreatitis

604

Introduction

604

Disease Relapse after Steroids and Treatment

604

Loss of Pancreatic Function and Evolution Toward Chronic Pancreatitis

606

Risk for Pancreatic and Extrapancreatic Cancer

607

References

607

Section 6 Neoplastic Tumors of the Exocrine Tissue: Benign Cystic Neoplasms of the Pancreas

609

Chapter 73 Epidemiology of Cystic Neoplasms of the Pancreas

611

Introduction

611

Pancreatic Cyst Lesions

611

Pancreatic Cystic Neoplasms

613

References

615

Chapter 74 Histologic Classification and Staging of Cystic Neoplasms

617

Introduction

617

Serous Cystic Neoplasms

617

Mucinous Cystic Neoplasm

618

Intraductal Papillary Mucinous Neoplasm

619

Solid Pseudopapillary Neoplasm

621

Acinar Cell Cystadenoma

622

Mature Cystic Teratoma

622

References

622

Chapter 75 Molecular Mechanisms of Cystic Neoplasia

624

Introduction

624

Serous Cystic Neoplasm

624

Intraductal Papillary Mucinous Neoplasm

625

Mucinous Cystic Neoplasm

628

Solid-Pseudopapillary Neoplasm

628

Other Cystic Neoplasms of the Pancreas

628

Clinical Applications

628

Implications for Families

629

Conclusions

629

References

629

Chapter 76 Clinical Presentation of Cystic Neoplasms

633

Introduction

633

Classification

633

General Clinical Presentation of Pancreatic Cysts

633

Clinical Presentation and Characteristics of Serous Cystic Neoplasms

633

Clinical Presentation and Characteristics of Mucinous Cystic Neoplasms

634

Clinical Presentation and Characteristics of Intraductal Papillary Mucous Neoplasms

635

Clinical Presentation and Characteristics of Solid-Pseudopapillary Neoplasms

635

Clinical Presentation and Characteristics of Cystic Pancreatic Neuroendocrine Neoplasms

635

References

635

Chapter 77 Evaluation of Cystic Lesions Using EUS, MRI, and CT

637

Introduction

637

Low-Risk Pancreatic Cysts

637

Pancreatic Cysts with Malignant Potential

640

Future Technology

644

Acknowledgment

645

References

645

Chapter 78 Cytologic Evaluation of Cystic Neoplasms

647

Introduction

647

Cytology of Neoplastic Cysts

647

Summary

651

References

653

Chapter 79 Natural History of Cystic Neoplasms: IPMN, MCN, SCN, and SPN

655

Introduction

655

Intraductal Papillary Mucinous Neoplasms

655

Mucinous Cystic Neoplasms

658

Serous Cystic Neoplasms

658

Solid-Pseudopapillary Neoplasm

659

References

659

Chapter 80 Surveillance or Surgical Treatment in Asymptomatic Cystic Neoplasms

662

Introduction

662

Rationale for Surveillance or Surgery in Asymptomatic Cystic Neoplasms

662

Treatment Guidelines for Asymptomatic Cystic Neoplasms

663

Quality of Life, Surgery Versus Surveillance

663

Cost-Effectiveness of Each Approach

664

References

665

Local and Standard Surgical Treatment of Cystic Neoplasms

666

Chapter 81 Duodenum-Preserving Partial or Total Pancreatic Head Resection

666

Background

666

Classical Pancreatoduodenectomy or Local Extirpation for Cystic Neoplasms of the Pancreatic Head?

666

Rationale for Local Pancreatic Head Resection

667

Duodenum-Preserving Total Pancreatic Head Resection With or Without Segmental Resection of the Peripapillary Duodenum and the Intrapancreatic Common Bile Duct

667

Conclusion

669

Acknowledgment

669

References

670

Chapter 82 Pancreatic Middle Segment Resection

671

Introduction

671

Indications

671

Contraindications

671

Technique

673

Results

674

Conclusions

674

References

674

Chapter 83 The Indications For and Limitations of Tumor Enucleation

676

Introduction

676

Indications

676

Contraindications

677

Surgical Technique

678

Postoperative Management

679

Complications

679

Outcomes

679

Contraindications

681

Cyst Ablation

681

Conclusions

682

References

683

Chapter 84 Standard Surgical Management of IPMN, MCN, SPN, and SCN Lesions: Open Approach

685

Introduction

685

Pancreatic Cystic Neoplasm Subtypes, Surgical Indications, and Operative Intervention

685

Pancreatectomy

687

Conclusion

690

References

690

Chapter 85 Surgical Treatment of Cystic Neoplasms: Laparoscopic Approach

693

Introduction

693

Specific Surgical Considerations and Procedures

693

Future Perspectives

695

References

696

Chapter 86 Management of Recurrence of Cystic Neoplasms

699

Introduction

699

Fate of the Pancreatic Remnant

699

Predictors of Recurrence

700

Low-Risk Lesions Left Behind in Remnant

701

Postoperative Surveillance Strategy

701

Conclusions

702

References

702

Long-Term Outcome of Management of Cystic Neoplasms

704

Chapter 87 Long-Term Outcome After Observation and Surgical Treatment: What is the Evidence?

704

Introduction

704

Serous Cystic Neoplasms

704

Mucinous Cystic Neoplasms

705

Intraductal Papillary Mucinous Neoplasms

705

Solid Pseudopapillary Neoplasms

707

Final Remarks

707

References

707

Section 7 Neoplastic Tumors of Exocrine Tissue: Pancreatic Cancer

709

Chapter 88 Epidemiology of Pancreatic Cancer

711

Incidence, Mortality Trends, Survival Prognosis

711

Cigarette Smoking

711

Diabetes

712

Body Mass Index

712

Alcohol

712

Pancreatitis

713

Dietary Factors

713

Gastrointestinal Microbiome

713

Allergy

713

Family History

714

Conclusions

714

References

714

Chapter 89 Smoking, a Risk for Pancreatic Cancer: Experimental and Clinical Data

717

Introduction

717

Experimental Data Regarding Smoking: A Risk Factor for Pancreatic Cancer

717

Clinical Data Supporting the Experimental Findings

720

Summary

720

References

721

Chapter 90 Molecular Understanding of Development of Ductal Pancreatic Cancer

723

Introduction

723

Genetic Alterations: The Four Mountains

724

Genetic Alterations: The Hills

725

Chromosome Instability

725

Microsatellite Instability

725

Mitochondrial Gene Mutations

726

Expression Changes

726

Precursor Lesions

726

Neoplasms with Acinar Differentiation

727

Clinical Applications

727

Summary and Conclusions

728

References

728

Chapter 91 Familial Pancreatic Cancer

732

Introduction

732

Familial Pancreatic Cancer

732

Pathology of Familial Pancreatic Cancer

732

Common Genetic Variants

734

Summary

734

References

734

Chapter 92 Pathology of Exocrine Pancreatic Tumors

737

Introduction

737

Ductal Adenocarcinoma

737

Cystic Neoplasms

740

Acinar Cell Lesions

743

Conclusions

745

References

745

Chapter 93 Pancreatic Cancer: Precancerous Lesions

749

Introduction

749

Pancreatic Intraepithelial Neoplasia

749

Intraductal Papillary Mucinous Neoplasm

751

Intraductal Tubulopapillary Neoplasm

753

Mucinous Cystic Neoplasms

754

Acknowledgments

755

References

755

Chapter 94 Clinical History and Risk Factors of Pancreatic Cancer

761

Introduction

761

Clinical History of Pancreatic Cancer

761

Risk Factors for Pancreatic Cancer

763

Conclusion

765

References

766

Chapter 95 Pancreatic Cancer Within the Uncinate Process: Radiologic and Clinical Characteristics

768

Embryology of the Pancreas

768

Radiologic Characteristics

768

Clinical Characteristics of the Uncinate Process Pancreatic Cancer (UPDAC)

769

References

771

Chapter 96 The Role of EUS in the Diagnosis and Differential Diagnosis of Neoplastic Lesions

772

Introduction

772

Characteristics of Endoscopic Ultrasound

772

New Screening Modality Comprising Contrast EUS and Elastography

772

EUS-FNA for Solid Pancreatic Lesions (Figs 96.2 and 96.3)

773

Diagnostic Yield and Safety of EUS-FNA for Solid Pancreatic Lesions

773

Factors Affecting EUS-FNA Procedures

775

References

775

Chapter 97 Radiologic Diagnosis of Pancreatic Cancer: CT, MRI

777

Introduction

777

Multidetector Computed Tomography

777

Magnetic Resonance Imaging

782

Conclusion

785

References

787

Chapter 98 Screening of Patients with Hereditary Pancreatic Cancer

789

Pancreatic Cancer Risk and Pancreatic Screening

789

At What Age Should Pancreatic Screening Begin and End?

791

Pancreatic Screening Tests

791

Lesions Identified by Pancreatic Screening

791

Pancreatic Pathology not Detected by Current Screening Tests

792

Surveillance

792

Surgery for Lesions Identified by Pancreatic Screening

793

Developing Better Pancreatic Screening Tests

793

Evaluating the Long-Term Outcomes of Patients who Undergo Pancreatic Screening

794

Summary

794

Acknowledgments

794

References

794

Chapter 99 The Role of ?PET?in Diagnosis of Pancreatic Cancer and Cancer Recurrence

799

Introduction

799

The Role of ?PET?and ?PET-CT?in Primary Tumor Diagnostic of Pancreatic Carcinoma

799

The Role of PET?and PET-CT?in Oncologic Staging of Pancreatic Carcinoma

800

Therapy Control and Diagnostics of Malignant Pancreatic Tumor Recurrence by PET?and PET?CT

801

Potential Value of PET-MRI?in Patients with Pancreatic Cancer

802

Conclusion

803

References

804

Chapter 100 Tumor Markers in Pancreatic Malignancies

806

Conventional Tumor Markers for Pancreatic Cancer

806

Other Markers for Pancreatic Malignancies

807

Novel Markers for Pancreatic Cancer

807

References

808

Chapter 101 The Role of Laparoscopy and Peritoneal Cytology in the Management of Pancreatic Cancer

810

Introduction

810

Laparoscopy

810

Peritoneal Cytology

811

References

812

Chapter 102 Clinical Assessment and Staging of Advanced Pancreatic Cancer

814

Introduction

814

Clinical Presentation

814

Evaluation for Pancreatic Cancer

814

Staging for Advanced Pancreatic Cancer

816

Conclusion

817

References

818

Surgical Treatment of Pancreatic Cancer

820

Chapter 103 Pancreatic Cancer: Indications for Resection

820

Introduction

820

Clinical Criteria for Resection

820

Surgical Criteria for Resection

821

Surgery for Pancreatic Cancer

821

Local Invasion

822

Extrapancreatic Nerve Plexus Invasion

822

Vascular Invasion

822

Lymph Node Metastases

823

Peritoneal Metastases

823

Liver Metastases

824

Other Distant Metastases

824

Effect of Clinical Volume

824

References

824

Chapter 104 Pancreaticoduodenectomy for Pancreatic Cancer, Short- and Long-Term Outcomes After Kausch–Whipple and Pylorus-Preserving Resection

827

Introduction

827

Short-Term Outcome

827

Long-Term Outcome

829

Future Trends

831

References

831

Chapter 105 Left Pancreatectomy for Body and Tail Cancer

834

Introduction

834

Tumor Staging and Resection Eligibility

834

Surgical Technique

834

Minimally Invasive Left Pancreatectomy

836

Postoperative Considerations

837

Conclusions

838

References

838

Chapter 106 Total Pancreatectomy: Indications and Limitations

841

Total Pancreatectomy

841

Elective Total Pancreatectomy and Salvage Completion Pancreatectomy

841

Perioperative Outcomes After Total Pancreatectomy

842

Long-Term Outcomes After Total Pancreatectomy

842

Indications for Total Pancreatectomy

844

Limitations of Total Pancreatectomy

845

References

845

Chapter 107 Laparoscopic and Robotic Resection for Pancreatic Cancer

848

Introduction

848

Patient Selection and Indications for the?MIS?Approach to Pancreaticoduodenectomy

848

Laparoscopic Pancreaticoduodenectomy

848

Robotic Pancreaticoduodenectomy

849

Indications for the MIS?Approach to the Distal Pancreatectomy

852

Laparoscopic Distal Pancreatectomy

852

Robot-Assisted Distal Pancreatectomy

854

Adopting the?MIS?Pancreatectomy: The Learning Curve

855

Conclusion

856

References

856

Chapter 108 Extended Radical Surgery for Pancreatic Cancer

858

Introduction

858

Surgical Procedures and Outcomes

859

Postoperative Outcome of Extended Surgical Approaches

862

References

863

Chapter 109 Palliative Pancreatoduodenectomy: Benefits and Limitations

867

Introduction

867

Definition of Palliative Resection

867

Review of the Literature

867

Management of Preoperatively Under?Staged Patients

869

Conclusions

869

References

870

Chapter 110 Bypass Surgery for Advanced Pancreatic Cancer

872

Introduction

872

Background

872

Symptoms

872

Endoscopic or Interventional Biliary Decompression

873

Surgical Bypass: Techniques

873

Endoscopic Versus Surgical Bypass

873

Gastric Decompression

875

Surgical Technique

875

Comparison of Surgical Gastric Decompression with Nonsurgical Management

875

Our Approach

875

References

876

Nonsurgical Palliation of Pancreatic Cancer

879

Chapter 111 Endoscopic and Interventional Palliation of Pancreatic Cancer

879

Introduction

879

Biliary Obstruction

879

Malignant Gastric Outlet Obstruction

881

Pain Management Derived from Cancer

882

Anticancer Therapy

883

Miscellaneous

883

Acknowledgment

883

References

883

Medical Treatment of Pancreatic Cancer

886

Chapter 112 Neoadjuvant Treatment of Pancreatic Cancer: Downstaging Results

886

Introduction

886

Neoadjuvant Therapy for Resectable Pancreatic Cancer

886

Emerging Recognition of Borderline Resectable Pancreatic Cancer

887

Downstaging Borderline Resectable Disease with Neoadjuvant Therapy

887

Challenges of Neoadjuvant Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer

888

Future Directions

888

Summary

889

References

889

Chapter 113 Adjuvant Chemotherapy in Pancreatic Cancer

891

Introduction

891

Rationale for Adjuvant Therapy

891

Adjuvant Chemoradiotherapy

895

Future Directions in Adjuvant Therapy

896

Timing and Duration of Adjuvant Therapy

897

Conclusions

897

References

898

Chapter 114 Immunotherapy for Pancreatic Cancer

900

Introduction

900

Immunology of Pancreatic Cancer

900

Therapeutic Vaccines

902

Non-Vaccine Immunomodulators Used in Pancreatic Cancer

904

Targeting Tumor-Associated Macrophages

905

Combination Immunotherapy

905

Conclusion

905

References

905

Chapter 115 Targeted Therapies for Pancreatic Cancer

909

Introduction

909

Genomic Landscape of PDAC

909

Molecular Subtypes Reveal Therapeutic Vulnerabilities

909

Targeting RAS

911

MEK/ERK Inhibition

911

Epidermal Growth Factor Receptor Inhibition

911

Insulin Growth Factor-1 Receptor

912

Pancreatic Stroma

912

Enabling Targeted Therapies in Pancreatic Cancer

912

Summary

913

References

913

Chapter 116 Palliative Chemotherapy for Advanced Pancreatic Cancer: Survival Benefit and Side Effects of Treatment

916

The Clinical Burden of Advanced Pancreatic Cancer

916

The Management of Advanced Pancreatic Carcinoma

916

References

921

Chapter 117 Management of Pain in Pancreatic Cancer

923

Anatomy and Physiology of Pancreas Cancer Pain

923

Pharmacologic Pain Management

923

Chemical Ablation of the Splanchnic Nerves or Celiac Plexus

924

Surgical Options for Treatment of Pancreatic Cancer

926

References

927

Chapter 118 Role of Radio and Proton Beam Therapy for Pancreatic Cancer

930

Introduction

930

Radiation in the Adjuvant Setting

930

Radiation in Borderline Resectable and Locally Advanced Disease

931

Proton Beam Therapy

932

Future Directions

935

References

935

Chapter 119 Management of Cancer Recurrence

939

Introduction

939

Incidence, Timing, and Pattern of Recurrence

939

Surveillance After Resection for Pancreatic Cancer

942

Treatment of Systemic Recurrence of Pancreatic Cancer

945

Treatment of Isolated Local Recurrence of Pancreatic Cancer

945

Rationale for “Local” Therapy Options

945

Chemoradiation for Isolated Local Recurrence

945

Re-resection for Isolated Local Recurrence

0

Selection of Patients for Local Therapy

0

Conclusions

0

References

0

Long-Term Outcome After Treatment of Pancreatic Cancer

950

Chapter 120 Survival and Late Morbidity After Resection of Pancreatic Cancer

950

Introduction

950

Survival after Resection for Pancreatic Cancer

950

Prognostic Risk Factors

953

Long-Term Morbidity

954

Conclusions

957

References

957

Section 8 Neoplastic Tumors of the Endocrine Pancreas: Neuroendocrine Tumors of the Pancreas

963

Chapter 121 Epidemiology and Classification of Neuroendocrine Tumors of the Pancreas

965

Introduction

965

Epidemiology of Pancreatic Neuroendocrine Tumors (Table 121.1)

965

Classification

966

Conclusions

971

Chapter 122 Pathology of Neuroendocrine Neoplasms

974

WHO Classification and TNM Classification

974

Macroscopy

974

Microscopy

975

Cytology

978

Immunohistochemistry and Differential Diagnosis

978

References

980

Chapter 123 Molecular Genetics of Neuroendocrine Tumors

981

Introduction

981

Genetics of Sporadic PanNET

981

Pathways Altered in PanNETs

982

High-Grade Neuroendocrine Carcinomas

985

Comparison of the PanNET Genetic Landscape with Other Pancreatic Neoplasias

985

Familial Syndromes

986

Epigenetics

986

Clinical Implications

987

Conclusions

987

References

988

Chapter 124 Clinical Manifestation of Endocrine Tumors of the Pancreas

991

Introduction

991

Epidemiology of PanNET

991

Clinical Symptoms of PanNET

991

Diagnosis of PanNET

993

References

995

Chapter 125 Evidence of Hormonal, Laboratory, Biochemical, and Instrumental Diagnostics of Neuroendocrine Tumors of the Pancreas

997

Introduction

997

Serum-Based Laboratory Investigations

997

Instrumental and Invasive Investigations

1001

Imaging

1001

Conclusions

1003

References

1003

Chapter 126 Pancreatic Neuroendocrine Tumors in Multiple Neoplasia Syndromes

1005

Introduction

1005

Epidemiology

1005

Genetics

1005

Diagnosis

1006

Clinical Presentation

1007

Surgical Treatment

1007

Medical Treatment

1008

Prognosis

1008

References

1009

Chapter 127 Nonfunctioning Pancreatic Neuroendocrine Tumors: Diagnosis and Management Principles

1011

Definition

1011

Pathology

1011

Mechanism of Tumorigenicity

1011

Clinical Findings

1011

Symptoms

1012

Diagnosis

1012

Surgical Treatment for Localized Lesions

1012

Multidisciplinary Treatment for Metastatic Lesions

1013

References

1015

Chapter 128 Medical and Nucleotide Treatment of Neuroendocrine Tumors of the Pancreas

1016

Introduction

1016

Nonsurgical Treatment of the Secretory Syndromes

1016

Nonsurgical Treatment Directed Against Tumor Growth

1018

Conclusions

1021

References

1021

Chapter 129 Interventional Radiology in the Treatment of Pancreatic Neuroendocrine Tumors

1023

Type of Interventional Radiology Treatment

1023

TAE/TACE

1023

RFA

1024

References

1025

Surgical Management of Endocrine Tumors of the Pancreas

1026

Chapter 130 Surgical Treatment of Endocrine Tumors: Enucleation

1026

Introduction

1026

Observation Versus Surgery for Small Sporadic, Benign?Appearing, Nonfunctioning Pancreatic Neuroendocrine Tumors

1026

Preoperative Imaging and Assessment of Proliferative Tumor Activity

1026

Surgical Technique of Enucleation

1027

Short- and Long-Term Outcomes After Enucleation

1028

Outcome After Laparoscopic Enucleation

1030

References

1030

Chapter 131 Local Treatment of Endocrine Tumors: Duodenum-Preserving Partial or Total Pancreatic Head Resection and Pancreatic Middle-Segment Resection

1033

Background

1033

Surveillance or Treatment of Neuroendocrine Tumors of the Pancreas?

1033

Indication for Surgical Treatment of PanNETs

1034

Parenchyma-Sparing Local Resection of Neuroendocrine Tumors of the Pancreatic Head

1034

Duodenum-Preserving Total or Partial Pancreatic Head Resection

1034

Pancreatic Middle?Segment Resection

1035

Conclusion

1036

Acknowledgment

1036

References

1037

Chapter 132 Surgical Treatment of Endocrine Tumors: Major Oncologic Resection

1038

Introduction

1038

Clinical Workup of Advanced PanNET for Major Oncologic Resection

1038

Surgical Approach to Locally Advanced Nonfunctioning PanNET Without Clinical Evidence of Distant Metastases

1039

Locally Advanced Nonfunctioning PanNET with Clinical Evidence of Distant Metastases

1042

References

1042

Chapter 133 Management of Insulinoma

1046

Introduction

1046

Clinical Features of Insulinomas

1046

Diagnosis of Insulinomas

1046

Localization of Insulinomas

1047

Treatment of Insulinomas

1049

References

1050

Chapter 134 Evidence of Medical and Surgical Treatment of Gastrinoma

1053

Treatment Strategy

1053

Tumor Localization

1053

Surgery

1054

Treatment of Hepatic Metastases

1055

Systemic Chemotherapy

1055

References

1055

Chapter 135 Rare Neuroendocrine Tumors of the Pancreas: Management and Evidence of Surgical Treatment

1057

Introduction

1057

Clinical Features

1057

Prognosis and Survival

1059

Diagnosis

1059

Tumor Localization

1059

Surgical Treatment

1060

Medical Treatment

1060

References

1061

Chapter 136 Treatment of Neuroendocrine Tumors of the Pancreas and Biliary Tract

1063

Introduction

1063

Neuroendocrine Tumors of the Pancreas

1063

Neuroendocrine Tumors of the Duodenum

1066

Neuroendocrine Tumors of the Liver

1068

Neuroendocrine Tumors of the Extrahepatic Biliary Tract

1068

Neuroendocrine Tumors of the Gallbladder

1069

References

1069

Long-Term Outcome After Treatment of Neuroendocrine Tumors of the Pancreas

1073

Chapter 137 Long-Term Outcome After Treatment of Endocrine Tumors

1073

Introduction

1073

Risk Stratification of Pancreatic Endocrine Tumors

1073

Surgical Considerations for Pancreatic Endocrine Tumors

1074

Conclusion

1077

References

1077

Section 9 Periampullary Cancers and Tumors Other Than Pancreatic Cancer

1079

Chapter 138 Periampullary Cancer: Clinical Presentation and Diagnostic Strategies

1081

Introduction

1081

Clinical Presentation

1081

Diagnostic Evaluation

1082

Determination of Extent of Resection

1087

Summary

1088

References

1088

Chapter 139 Histology and Genetics of Cancer of the Papilla, Distal Common Bile Duct, and Duodenum

1091

Carcinoma of Papilla (Ampulla of Vater)

1091

Distal Common Bile Duct Carcinoma

1095

Nonampullary Duodenal Carcinoma

1096

Pathologic Staging of Cancers of this Region

1097

Neuroendocrine Neoplasms and Related Tumors

1097

Pseudotumors that Commonly Mimic Cancer

1097

Secondary Tumors

1098

References

1098

Chapter 140 Adenoma and Adenocarcinoma of the Ampulla of Vater: Diagnosis and Management

1102

Introduction

1102

Epidemiology and Biologic Behavior

1102

Pathology and Pathogenesis

1102

Clinical Features

1103

Diagnosis and Staging of Ampullary Malignancy

1103

Management and Treatment

1105

Posttreatment Surveillance

1107

Long-Term Results of Surgical Resection

1107

References

1107

Chapter 141 Endoscopic Treatment of Adenomas of the Ampulla of Vater: Techniques, Results, Benefits, and Limitations

1112

Introduction

1112

Endoscopic Papillectomy

1112

Preprocedural Evaluation

1112

Techniques

1113

Clinical Results

1115

Complications

1115

Postprocedural Surveillance

1116

Conclusions

1116

References

1116

Chapter 142 Surgical Treatment of Adenoma and Cancer of Papilla of Vater

1118

Introduction

1118

Molecular Pathology of Ampullary Cancer

1118

Endoscopic and Surgical Treatment of Large Adenomas and Carcinoma of the Ampulla of Vater

1119

Ampullectomy for Large Adenomas and Low-Risk Ampullary Cancer

1120

Pancreatoduodenectomy for Advanced Ampullary Cancer

1120

Survival After Ampullectomy and Pancreatoduodenectomy

1121

Conclusion

1121

Acknowledgment

1122

References

1122

Chapter 143 Surgical Treatment of Duodenal Cancer

1125

References

1126

Chapter 144 Surgical Treatment of Distal Cholangiocarcinoma

1127

Introduction

1127

Pyloric Ring Preservation

1127

Lymph Node Dissection

1128

Skeletonization of the Hepatoduodenal Ligament and Dissection of Pancreatic Head Neural Plexus

1130

Bile Duct Cut Margin

1130

Surgery-Related Complications

1131

Summary

1131

References

1131

Chapter 145 Adjuvant and Palliative Chemotherapy of Periampullary Cancers

1133

Introduction

1133

Distal Cholangiocarcinoma

1133

Duodenal Adenocarcinoma

1136

Ampullary Carcinoma

1137

Conclusion

1138

References

1138

Long-Term Survival After Tumor Resection

1141

Chapter 146 Long-Term Survival After Resection of Periampullary Cancer

1141

Introduction

1141

Distal Bile Duct Cancer

1141

Ampullary Region Cancer

1143

Duodenal Cancer

1146

References

1148

Section 10 Transplantation of the Pancreas

1151

Chapter 147 Transplantation of Pancreatic Islets

1153

Introduction

1153

Manufacturing, Release Testing, and Infusion of Allogeneic Human Islets

1153

Selection of Islet Allotransplant Recipients

1153

Outcomes of Islet Allotransplantation in T1D

1156

Adverse Effects of Islet Transplantation and Immunosuppression

1158

Outcomes of Islet Autotransplantation in Chronic Pancreatitis

1159

Research Priorities in Islet Transplantation

1159

Conclusions

1160

Acknowledgments

1160

References

1160

Chapter 148 Transplantation of the Pancreas

1165

Introduction

1165

Epidemiology and Sequelae of Insulin-Dependent Diabetes Mellitus

1165

Historical Aspects

1165

Indications for Pancreas Transplantation

1166

Preoperative Workup and Cardiac Risk Assessment

1167

Donor Selection and Donor Pancreatectomy

1167

Donor Operation

1167

Deceased Cardiac Death Donors (DCD)

1168

Preservation

1168

Technical Aspects of the Recipient Operation

1168

Current Status and Results of Pancreas Transplantation in the United States

1171

Conclusion

1171

References

1171

Index

1173

EULA

1219